Loading

Panel: Charting the way forward: Where are we heading?

04 Sep 2025
Plenary
Plenary
As we wrap up two days of deep discussions on the current state of the European CGT landscape, this final panel will chart the path ahead. Which steps must Europe take to remain competitive and lead the way in the next 5–10 years? Each panellist will share their key takeaways from the last two days, reflecting on the insights, challenges, and opportunities discussed. 
Chairperson
Montse Daban, Executive Director - BIOCAT
Speakers
Angela Vollstedt, Director Global Cell & Gene Therapies Portfolio - Novartis
Miguel Forte, Chief Executive Officer & President, ISCT - Kiji Therapeutics
Raphael Ognar, Chief Executive Officer - NKILT Therapeutics
Bernd Eschgfäller, Independent Board Member - T-CURX